ArticleFrontiers in oncology2020

Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway.

Ke Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.